HETEROCYCLIC CONDENSED IMIDAZOLE DERIVATIVES HAVING AMPK ACTIVATION ACTION

PROBLEM TO BE SOLVED: To provide pharmaceutical compositions having an action to activate adenosine monophosphate-activating protein kinase for treating diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and/or hypertension.SOLUTION: Provided is a composition comprising an i...

Full description

Saved in:
Bibliographic Details
Main Authors FUJIOKA MASAHIKO, KOJIMA EIICHI, TANAKA NOBUYUKI, TONOGAKI KEISUKE, KATO MANABU, INO AKIRA, IWATSU MASAFUMI
Format Patent
LanguageEnglish
Japanese
Published 22.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PROBLEM TO BE SOLVED: To provide pharmaceutical compositions having an action to activate adenosine monophosphate-activating protein kinase for treating diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and/or hypertension.SOLUTION: Provided is a composition comprising an imidazo[4,5-a] pyridine compound of the formula in which A is a pyridine ring; Ris independently halogen, hydroxyl, cyano, nitro, carboxy, substituted or unsubstituted alkyl, or substituted or unsubstituted alkenyl; m is an integer of 0-3; Ris hydrogen, or substituted or unsubstituted alkyl; X is -O-; Y is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl or substituted or unsubstituted heterocyclyl. 【課題】アデノシン一リン酸活性化プロテインキナーゼ活性化作用を有する糖尿病、高血糖症、メタボリックシンドローム、肥満、高コレステロール血症及び/又は高血圧治療用医薬組成物の提供。【解決手段】下式で表されるイミダゾ[4,5−a]ピリジン化合物を含有する組成物。[A部はピリジン環;R1は各々独立にハロゲン、ヒドロキシ、シアノ、ニトロ、カルボキシ、置換若しくは非置換のアルキル、置換若しくは非置換のアルケニル等;mは0〜3の整数;R2は水素又は置換若しくは非置換のアルキル;Xは−O−;Yは置換若しくは非置換のアリール、置換若しくは非置換のヘテロアリール、置換若しくは非置換のシクロアルキル、置換若しくは非置換のシクロアルケニル又は置換若しくは非置換のヘテロサイクリル)【選択図】なし
AbstractList PROBLEM TO BE SOLVED: To provide pharmaceutical compositions having an action to activate adenosine monophosphate-activating protein kinase for treating diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and/or hypertension.SOLUTION: Provided is a composition comprising an imidazo[4,5-a] pyridine compound of the formula in which A is a pyridine ring; Ris independently halogen, hydroxyl, cyano, nitro, carboxy, substituted or unsubstituted alkyl, or substituted or unsubstituted alkenyl; m is an integer of 0-3; Ris hydrogen, or substituted or unsubstituted alkyl; X is -O-; Y is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl or substituted or unsubstituted heterocyclyl. 【課題】アデノシン一リン酸活性化プロテインキナーゼ活性化作用を有する糖尿病、高血糖症、メタボリックシンドローム、肥満、高コレステロール血症及び/又は高血圧治療用医薬組成物の提供。【解決手段】下式で表されるイミダゾ[4,5−a]ピリジン化合物を含有する組成物。[A部はピリジン環;R1は各々独立にハロゲン、ヒドロキシ、シアノ、ニトロ、カルボキシ、置換若しくは非置換のアルキル、置換若しくは非置換のアルケニル等;mは0〜3の整数;R2は水素又は置換若しくは非置換のアルキル;Xは−O−;Yは置換若しくは非置換のアリール、置換若しくは非置換のヘテロアリール、置換若しくは非置換のシクロアルキル、置換若しくは非置換のシクロアルケニル又は置換若しくは非置換のヘテロサイクリル)【選択図】なし
Author TANAKA NOBUYUKI
FUJIOKA MASAHIKO
INO AKIRA
KATO MANABU
IWATSU MASAFUMI
KOJIMA EIICHI
TONOGAKI KEISUKE
Author_xml – fullname: FUJIOKA MASAHIKO
– fullname: KOJIMA EIICHI
– fullname: TANAKA NOBUYUKI
– fullname: TONOGAKI KEISUKE
– fullname: KATO MANABU
– fullname: INO AKIRA
– fullname: IWATSU MASAFUMI
BookMark eNrjYmDJy89L5WTw8nANcQ3yd4509vF0VnD293Nx9Qt2dVHw9PV0cYzy93FVcHEN8gxzDPEMcw1W8HAM8_RzV3D0DfBWcHQOAYv7-4GZ_n48DKxpiTnFqbxQmptByc01xNlDN7UgPz61uCAxOTUvtSTeK8DIwNDUwNDYwtzM0ZgoRQAANi_Q
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate AMPK活性化作用を有するヘテロ環縮合イミダゾール誘導体
ExternalDocumentID JP2015013876A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2015013876A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Japanese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2015013876A3
Notes Application Number: JP20140170005
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150122&DB=EPODOC&CC=JP&NR=2015013876A
ParticipantIDs epo_espacenet_JP2015013876A
PublicationCentury 2000
PublicationDate 20150122
PublicationDateYYYYMMDD 2015-01-22
PublicationDate_xml – month: 01
  year: 2015
  text: 20150122
  day: 22
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies SHIONOGI & CO LTD
RelatedCompanies_xml – name: SHIONOGI & CO LTD
Score 3.0823264
Snippet PROBLEM TO BE SOLVED: To provide pharmaceutical compositions having an action to activate adenosine monophosphate-activating protein kinase for treating...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title HETEROCYCLIC CONDENSED IMIDAZOLE DERIVATIVES HAVING AMPK ACTIVATION ACTION
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150122&DB=EPODOC&locale=&CC=JP&NR=2015013876A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUaOipjFmb4syBmMPxIy2OCZsi-CCvpCVjURNBpEZ_32vdShPvPUjadpLf_fV6x3AjbCnQsTNO72V2LZuClnIHa-ObiVW0hI1FCqxyvbpN91n0xs3xiX4WP2FUXlCv1VyRETUFPGeK369-HdiMRVbubwVbzg0v--O2kwrrGPUbmqGobFOm4cBC6hGadsLNf-pmKsj9p0t2EY92pLxXzzqyG8pi3WZ0j2AnRCXy_JDKL3HFdijq9JrFdgdFC_e2CzAtzwCz-Woewb0hfZ7lNDAZ9wfckaQ_TDnNehzwtAqi5xRL-JD4jpRz38gziB8JDJSJFLOKPIbNHIM110-oq6Om5r8kWDihWsHqJ9AOZtn6SkQgRhM4sbMsmcWql6GSGV2FjE1hGWiqRWfQXXDQucbZ6uwL3vS32AYF1DOP7_SS5TAubhSlPsBf-aC1Q
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT8IwFD5BNOKbokbFS2PM3hZlXMYeiBltcRtjW2Qu4AtZGSRqAkRm_PuezqE88db0JCdt06_n0tOvAHfCmAgRNx_UVmIYal3Ij9xx66h6oictUUWjEmdsn17Teqk7w8awAB_rtzAZT-h3Ro6IiJog3tPsvF7-J7FYVlu5uhdv2LV47IZtpuTRMXo3VU1TWKfNA5_5VKG07QSK95zLaoh9cwd20cduSaJ9HnXks5Tlpk3pHsJegOrm6REU3uMylOj667Uy7PfzG29s5uBbHYNjcfQ9fTqirk0J9T3GvQFnBI8fZr76LicMo7LIDO2ID4hlRrb3RMx-0COyUiTKklHkt2jkBG67PKSWioMa_y3B2Ak2JlA7heJ8MZ-eARGIwSRuzHRjpqPrpYmpZGcRE03odQy14nOobFF0sVV6AyUr7Ltj1_Z6FTiQEpl70LRLKKafX9MrtMapuM5W8QfLEoXF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HETEROCYCLIC+CONDENSED+IMIDAZOLE+DERIVATIVES+HAVING+AMPK+ACTIVATION+ACTION&rft.inventor=FUJIOKA+MASAHIKO&rft.inventor=KOJIMA+EIICHI&rft.inventor=TANAKA+NOBUYUKI&rft.inventor=TONOGAKI+KEISUKE&rft.inventor=KATO+MANABU&rft.inventor=INO+AKIRA&rft.inventor=IWATSU+MASAFUMI&rft.date=2015-01-22&rft.externalDBID=A&rft.externalDocID=JP2015013876A